Gaudium IVF and Women Health Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 59.4%
- Company has a healthy return on capital (ROCE) of 58.5%
- Latest quarter profit grew 175.3% YoY, showing strong momentum
- Operating margins have improved to 40.8% from 37.0%
- Company comfortably covers its interest (16.5x coverage)
- Company maintains a comfortable, low leverage position
CONS
- Receivables are growing faster than sales - a possible quality concern
- Debtor days have increased from 55 to 120
- Inventory has been piling up - inventory days up from 14 to 24
- Though reporting repeated profits, the company pays out little dividend (0.0%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | 8670.00 | 59.66 | 124661.30 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| MANIPALHOS | 729.75 | 107.57 | 95989.65 | 0.00 | 2434.30 | — | 30906.30 | — | 13.93 | 23.83 |
| MAXHEALTH | 985.00 | 65.80 | 95867.73 | 0.20 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| FORTIS | 910.00 | 65.56 | 68701.19 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| ASTERDM | 785.80 | 214.94 | 68496.02 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.46 | 19.53 |
| MEDANTA | 1468.85 | 71.01 | 39493.23 | 0.03 | 157.25 | -1.09 | 1304.05 | 26.50 | 19.38 | 21.99 |
| NH | 1859.10 | 46.55 | 37992.72 | 0.24 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| KIMS | 764.15 | 157.10 | 32094.80 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| LALPATHLAB | 1874.90 | 58.07 | 31469.98 | 1.09 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| AGARWALEYE | 514.15 | 109.86 | 16299.90 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 16.14 | 27.75 |
| VIJAYA | 1496.35 | 82.20 | 15412.06 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.28 | 42.66 |
| GAUDIUMIVF | 116.25 | 34.59 | 846.15 | 0.00 | 17.76 | 175.31 | 193.77 | 619.69 | 50.15 | 12.51 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| 14 | 27 | 18 | 25 | 30 | 19 | |
| 9 | 18 | 14 | 18 | 18 | 18 | |
| Operating Profit | 6 | 9 | 4 | 7 | 12 | 1 |
| OPM % | 39.29% | 32.39% | 22.80% | 26.72% | 40.10% | 6.85% |
| 0 | 0 | 0 | 0 | 0 | 1 | |
| Interest | 0 | 0 | 0 | 1 | 1 | 0 |
| Depreciation | 1 | 0 | 1 | 0 | 1 | 1 |
| Profit before Tax | 5 | 8 | 4 | 5 | 10 | 2 |
| Tax % | 27.72% | 20.83% | 24.01% | 26.81% | 19.87% | 27.51% |
| Net Profit | 0 | 0 | 3 | 4 | 8 | 2 |
| 0.55 | 1.05 | 0.50 | 0.59 | 1.34 | 0.25 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 37 | 44 | 48 | 71 | 92 | |
| 23 | 24 | 28 | 42 | 68 | |
| Operating Profit | 14 | 20 | 19 | 29 | 24 |
| OPM % | 37.04% | 45.69% | 40.59% | 40.83% | 26.19% |
| 0 | 0 | 0 | 0 | 1 | |
| Interest | 1 | 0 | 1 | 2 | 3 |
| Depreciation | 1 | 1 | 2 | 2 | 2 |
| Profit before Tax | 12 | 18 | 17 | 25 | 22 |
| Tax % | 26.43% | 26.14% | 37.97% | 24.76% | 23.06% |
| Net Profit | 9 | 14 | 10 | 19 | 17 |
| EPS | 1.44 | 136.59 | 104.19 | 3.12 | — |
| Dividend Payout % | 0.00% | 46.95% | 0.00% | 0.00% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 25%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 29%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 59%
- Last Year:
- 52%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 31 |
| 8 | 22 | 26 | 16 | |
| 6 | 11 | 17 | 20 | |
| Trade Payables | 1 | 1 | 1 | 14 |
| 1 | 1 | 6 | 8 | |
| Total Liabilities | 18 | 37 | 51 | 89 |
| 4 | 18 | 19 | 18 | |
| 0 | 0 | 0 | 5 | |
| 0 | 1 | 2 | 7 | |
| 0 | 0 | 14 | 33 | |
| Cash & Bank | 2 | 15 | 12 | 7 |
| 12 | 2 | 5 | 18 | |
| Total Assets | 18 | 37 | 51 | 89 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 2 | 29 | 3 | 9 | |
| Cash from Investing | -1 | -16 | -5 | -15 |
| Cash from Financing | 3 | 5 | -1 | 2 |
| 0 | 13 | -3 | -5 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| PER SHARE | ||||
| EPS (₹) | 89.16 | 136.59 | 104.19 | 3.12 |
| Book Value (₹) | 93.86 | 229.55 | 272.53 | 7.54 |
| Dividend per Share (₹) | 0.00 | 64.13 | 0.00 | 0.00 |
| Cash EPS (₹) | 1.60 | 2.44 | 2.03 | 3.45 |
| PROFITABILITY | ||||
| Operating Margin % | 37.05% | 45.74% | 40.59% | 40.83% |
| Net Margin % | 24.17% | 30.57% | 21.54% | 27.05% |
| ROE % | 94.99% | 84.47% | 41.50% | 52.20% |
| ROCE % | 82.39% | 78.74% | 46.65% | 50.15% |
| 50.27% | 49.92% | 23.55% | 27.42% | |
| EFFICIENCY | ||||
| Debtor Days | 65 | 31 | 55 | 120 |
| Inventory Days | 3 | 8 | 14 | 24 |
| Payable Days | 114 | 87 | 72 | 178 |
| -46 | -49 | -3 | -34 | |
| FINANCIAL HEALTH | ||||
| Debt to Equity (x) | 0.64x | 0.43x | 0.58x | 0.41x |
| Interest Coverage (x) | 22.44x | 38.53x | 19.23x | 16.46x |
| 2.29x | 1.92x | 1.50x | 1.42x | |
| GROWTH | ||||
| Revenue Growth % | 0.00% | 21.13% | 8.26% | 47.68% |
| Operating Profit Growth % | 0.00% | 49.55% | -2.63% | 47.76% |
| Net Profit Growth % | 0.00% | 53.21% | -23.72% | 85.40% |
| 0.00% | 0.00% | -23.72% | -97.01% | |
| VALUATION | ||||
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.25x | 1.46x |
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-04 - Gaudium IVF and Women Health Limited has informed the Exchange about Intimation of Post Dispatch Newspaper Advertisement for the Notice of 11th Annual General Meeting and E-Voting Information.
2026-09-03 - Gaudium IVF and Women Health Limited has informed the Exchange regarding 'Letter Shareholders providing the weblink and navigation path for accessing the Annual Report for the Financial Year 2025-26 pursuant to Regulation 36(1)(b) of Listing Regulations.'
2026-09-03 - Gaudium IVF and Women Health Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026
2026-09-01 - Gaudium IVF and Women Health Limited has informed the Exchange about Copy of Newspaper Publication regarding Pre-AGM Notice of 11th Annual General Meeting to be on Monday, September 28, 2026, through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).
2026-08-19 - Gaudium IVF and Women Health Limited has informed the Exchange about Transcript of Earnings Call on Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
2026-08-14 - Gaudium IVF and Women Health Limited has informed the Exchange about Audio recording of the Earnings Call on the Financial Results for the quarter ended June 30, 2026.
2026-08-14 - Gaudium IVF and Women Health Limited has informed the Exchange about the Newspaper publication of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
2026-08-14 - Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation
2026-08-13 - Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation
News
Recent coverage and analyst commentary for GAUDIUMIVF
Loading news…
AI Stock Analyst
Gaudium IVF and Women Health Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account